Psychedelic Retreats

Most retreats specialize in one medicine because one medicine is what their facilitator knows. A clinical program starts from the opposite direction: what does this guest's history, medication load, and nervous system need, and which modality — if any — is indicated? Sanctuary Tulum offers four under one licensed roof.

• • Ibogaine treatment — an extracted, isolated alkaloid administered by physicians after cardiac clearance, with continuous EKG monitoring throughout. Used clinically for opioid use disorder, long-term benzodiazepine and SSRI dependence, and stalled recovery. Ibogaine is a medical treatment, not a ceremony, and any retreat that presents it as one should be treated as a warning sign. See also ibogaine treatment in Mexico.
• • Ayahuasca ceremonies — private ceremonies held in a medically supervised setting, screened for SSRI and MAOI contraindications, most often indicated for trauma, PTSD, and depression that has not moved under conventional care.
• • 5-MeO-DMT (bufo) ceremonies — short-duration, high-intensity sessions held under supervision and sequenced deliberately inside a broader program rather than sold as a standalone weekend.
• • Psilocybin ceremonies — supervised psilocybin sessions used for depression, end-of-life distress, and the emotional layer that tends to surface once physical detox is complete.

Around the medicine sits the rest of the protocol: the Brain Repair Protocol IV, hyperbaric oxygen therapy, ozone therapy, an organic non-GMO nutrition program, daily bodywork, yoga, and meditation — sequenced through the Pouyan Method™, our founder's proprietary, trademarked protocol. No pharmaceutical replacement drugs, no group therapy, no talk-therapy-only model.

A COFEPRIS license is not a marketing badge. It places a facility under a federal health regulator's requirements for facility standards, medical staffing, record-keeping, and inspection. That is the difference between a program that can escalate a medical event and a villa that has to call an ambulance from town.

The practical consequences guests feel are ordinary and unglamorous: an EKG before ibogaine rather than after a deposit clears; a physician in the room during the session rather than reachable by phone; nursing coverage overnight when the medicine's peak has passed but the nervous system is still working; emergency medications and IV access already in the treatment room; a written hospital transfer protocol to the full-service private hospitals along the Tulum–Playa del Carmen corridor.

Our full credential set, screening protocol, and monitoring standards are documented on the safest psychedelic facility page and overseen by our Medical Review Board. In more than a decade of medically supervised ibogaine administration — a medicine with real cardiac risk factors — Sanctuary Tulum has maintained a documented, fatality-free record, which is notable precisely because unregulated ibogaine operations elsewhere have not.

"Best" in this category is not an aesthetic judgment. Ranking lists are largely paid placement, and a beautiful website tells you nothing about who is in the room when a heart rate drops. Five questions separate serious facilities from everyone else, and every one of them is checkable before you pay anything.

• • Is the license verifiable? Ask for the license category and issuing authority, then confirm it covers medical treatment — not spa or hospitality services.
• • Are physicians on site or on call? On-site is the standard. On-call means the medical response starts with a phone call.
• • What is screened, and when? Cardiac clearance and lab work before ibogaine; SSRI, MAOI, and medication interaction review before ayahuasca; psychiatric history reviewed by a clinician, not a booking agent.
• • Group or private? Group ceremonies dilute supervision. Private sessions keep clinical attention where it belongs.
• • What happens after? Integration inside the stay and structured aftercare after discharge. Medicine without integration is an experience, not a treatment.

A sixth question is quieter and more revealing: will the facility say no? Any retreat that has never turned away a paying guest is not screening. Sanctuary Tulum declines applicants who cannot be safely cleared, and that decision is clinical rather than commercial.

The evidence base for supervised psychedelic-assisted care is now substantial enough to be discussed honestly. A randomized phase 3 trial of MDMA-assisted therapy for severe PTSD reported large reductions in symptom severity relative to placebo with therapy.^[1] A head-to-head trial of psilocybin against escitalopram for major depression found psilocybin performed comparably on the primary measure and favorably on several secondary ones.^[2] Observational data on ibogaine for opioid use disorder describes marked reductions in withdrawal and craving, alongside clearly documented cardiac risk that mandates screening and monitoring.^[3]

What the research does not support is any promise of a cure, a guaranteed outcome, or a single session that resolves years of dependence on its own. Every successful trial shares the same unglamorous features: careful selection, controlled dosing, medical monitoring, and structured preparation and integration. That is the design our program is built to mirror — the FDA's own guidance for psychedelic clinical investigations emphasizes the same elements.^[4]

Guests rarely arrive at a psychedelic retreat as a first step. Most have already been through conventional care that plateaued: years on SSRIs with a flattened baseline, a benzodiazepine taper that stalled, opioid dependence that survived multiple treatment episodes, PTSD that talk therapy circled without resolving, or a recovery from prior rehab that never fully took. Common presentations include benzodiazepine withdrawal, treatment-resistant depression, PTSD and trauma, and alcohol or opioid dependence.

For that population the retreat framing can be misleading — what they need is a medical program that happens to be held in a beautiful place, not a vacation with medicine attached. That is why our programs also read as luxury rehab program and luxury detox: same license, same physicians, same protocol, different entry point.

Common Mistakes When Booking a Psychedelic Retreat

The most frequent mistake is booking on aesthetics. Photography of a jungle platform or a candlelit maloca tells you what the space looks like, not who is present when a guest's blood pressure drops or a psychiatric history surfaces mid-ceremony. The second is booking on availability — a retreat that can take you next weekend is very often a retreat that has not asked for your medical records.

The third is choosing a medicine before a consultation. Guests frequently arrive certain that ayahuasca is the answer when their clinical picture points to detox and stabilization first, or convinced they need ibogaine when their history includes a cardiac contraindication. Deciding the modality yourself and then finding a provider willing to deliver it inverts the order of a clinical process.